Sai Life Sciences files FY26 BRSR and ESG Databook on August 25
- Filed BRSR and ESG Databook for FY26 on August 25, 2026
- Scope 1 GHG emissions rose to 22,445 tCO2e while Scope 2 fell to 8,630 tCO2e
- Total energy consumption increased to 3,85,999 GJ with 1,77,993 GJ from renewables
- Permanent employee count reached 3,909 with turnover dropping to 20.98%
- Zero fatalities and zero lost-time injuries reported for the year
*this image is generated using AI for illustrative purposes only.
Sai Life Sciences filed its Business Responsibility and Sustainability Report (BRSR) and ESG Databook for the financial year ended March 31, 2026, with stock exchanges on August 25, 2026. The disclosure, submitted pursuant to Regulation 34(2)(f) of the SEBI LODR Regulations, forms part of the company's Integrated Annual Report.
The filing covers standalone operations, including manufacturing sites in Hyderabad and Bidar, alongside R&D facilities in the UK. TUV India Private Limited provided reasonable assurance for the BRSR Core indicators and limited assurance for selected non-core disclosures under ISAE 3000 (Revised).
Environmental Performance
The ESG Databook outlines key environmental metrics for FY26 compared to the previous year. Total energy consumption rose to 3,85,999 GJ from 3,15,631 GJ in FY25. Renewable energy sources accounted for 1,77,993 GJ, while non-renewable sources contributed 2,08,006 GJ.
Greenhouse gas emissions data shows a divergence between direct and indirect emissions. Scope 1 emissions increased to 22,445 tCO2e from 18,435 tCO2e. Conversely, Scope 2 market-based emissions fell sharply to 8,630 tCO2e from 15,638 tCO2e, reflecting the company's renewable energy procurement strategy. Scope 3 emissions stood at 90,272 tCO2e.
Water withdrawal totalled 1,83,967.92 kilolitres, with groundwater comprising 1,02,390.35 kilolitres. The company reported implementing Zero Liquid Discharge systems at its Bidar manufacturing facility.
Workforce and Social Metrics
As of March 31, 2026, Sai Life Sciences employed 3,909 permanent employees and 1,315 workers. Female representation among permanent employees was 15.14%, while the board of directors included one female member (17%). The turnover rate for permanent employees decreased to 20.98% in FY26 from 24.17% in FY25.
The company reported zero fatalities and zero lost-time injury frequency rates for both employees and workers during the year. One complaint regarding sexual harassment was filed and resolved under the POSH Act.
Governance and Compliance
The report highlights adherence to various international standards, including ISO 14001 for environmental management and ISO 45001 for occupational health and safety across all Indian sites. The company disclosed no monetary penalties or fines related to regulatory non-compliance in FY26.
Historical Stock Returns for Sai Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.36% | +2.76% | +18.05% | +54.36% | +60.48% | +90.35% |
How will the 22% increase in total energy consumption impact Sai Life Sciences' ability to meet future net-zero targets despite the reduction in Scope 2 emissions?
What specific strategies is the company planning to implement to address its significant Scope 3 emissions, which constitute over 60% of its total carbon footprint?
Could the reliance on groundwater for over 55% of water withdrawal expose the Bidar facility to regulatory or operational risks in water-stressed regions?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
